| Advances in hepato-pancreato biliary surgery. | |
| | |
MedLine Citation:
|
PMID: 21780892 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The Americas Hepato-Pancreato Biliary Association (AHPBA) Annual 2011 Meeting provided a forum for discussion of multidisciplinary advances surrounding six tracks including the liver, biliary system, liver transplantation, pancreas, imaging and biomedical engineering and general hepato-pancreato biliary (HPB) surgical disease. The meeting and postgraduate courses attracted the largest ever attendance and participation in the AHPBA annual meeting, including field leaders and participants from across North, Central and South America who interchanged clinical and scientific knowledge, and discussed advances in technology, care and outcomes for treatment of HPB diseases. The AHPBA Foundation, established in 2010, announced progress toward support of meritorious research in HPB disease and enrichment of educational programs. HPB fellowship graduates were recognized, marking successful establishment of the AHPBA as an important body guiding HPB education and training in the USA and the Americas. |
| | |
Authors:
|
Eddie K Abdalla |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Expert review of gastroenterology & hepatology Volume: 5 ISSN: 1747-4132 ISO Abbreviation: Expert Rev Gastroenterol Hepatol Publication Date: 2011 Aug |
Date Detail:
|
Created Date: 2011-07-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101278199 Medline TA: Expert Rev Gastroenterol Hepatol Country: England |
Other Details:
|
Languages: eng Pagination: 457-60 Citation Subset: IM |
Affiliation:
|
The University of Texas MD Anderson Cancer Center, 1400 Hermann Pressler Drive, Unit, 1484 Houston, TX 77030-4008, USA. eabdalla@mdanderson.org. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Reducing the risk of gastroduodenal ulcers with a fixed combination of esomeprazole and low-dose ace...
Next Document: The role of rifaximin therapy in patients with irritable bowel syndrome without constipation.